The Hemogenyx Pharmaceuticals (HEMO) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has increased 96,384.38%, with a year-to-date return of 207.21%. In the past month, the stock has increased 65.99%, reflecting recent market activity.
As of the latest close, Hemogenyx Pharmaceuticals traded at GBX 1,235 with a market cap of £66.21 million and volume of 33,840 shares. Five years ago, the stock traded at GBX 9.73, representing a 12,587.49% increase over that period. At the time, it had a market cap of £40.76 million and a volume of 3.17 million shares.
